I. Molecular targeting therapy and immunotherapy
Nishioka, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(8): 1004-1008
2013
ISSN/ISBN: 0385-0684 PMID: 24151656 Document Number: 671218
Document emailed within 1 workday
Related Documents
He, P.; Zhou, W.; Liu, M.; Chen, Y. 2019: Recent Advances of Small Molecular Regulators Targeting G Protein- Coupled Receptors Family for Oncology Immunotherapy Current Topics in Medicinal Chemistry 19(16): 1464-1483Demetter, P.; Maréchal, R.; Verset, L.; Salmon, I.; Bachet, J.-B.; Van Laethem, J.L. 2012: Molecular changes in pancreatic cancer: implications for molecular targeting therapy Acta Gastro-Enterologica Belgica 75(2): 210-214
Tabe, Y. 2009: Molecular diagnosis of and molecular targeting therapy for leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 57(2): 137-145
Uemura, H. 2012: Era of molecular targeting therapy in RCC Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 480-485
Hara, M.; Kinoshita, M. 2012: Molecular targeting therapy of dyslipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 618-622
Mima, T.; Nakashima, Y.; Hanba, Y.; Ohya, M.; Negi, S.; Shigematsu, T. 2012: Molecular targeting therapy in rheumatoid arthritis Nihon Jinzo Gakkai Shi 54(5): 603-609
Fujii, M. 2013: IV. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 867-870
Tahara, M. 2012: II. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(7): 1055-1060
Naka, N. 2012: II. Possibility of molecular targeting therapy for musculoskeletal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 373-377
Okamoto, I. 2008: Molecular targeting therapy for treatment of non-small-cell lung carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1303-1309
Katayose, Y.; Kudo, T.; Suzuki, M.; Shinoda, M.; Saijyo, S.; Sakurai, N.; Saeki, H.; Fukuhara, K.; Imai, K.; Matsuno, S. 1996: MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth Cancer Research 56(18): 4205-4212
Fujii, S.; Abe, M. 2012: Molecular targeting agents for multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 518-523
Takashima, A.; Fukuda, H.; Shibata, T. 2010: Development for and clinical trials of molecular targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
Okita, R.; Yamaguchi, Y.; Ohara, M.; Hironaka, K.; Okawaki, M.; Nagamine, I.; Ikeda, T.; Emi, A.; Hihara, J.; Okada, M. 2009: Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer International Journal of Oncology 34(2): 563-572
Van Adelsberg, J. 1998: Protein targeting: the molecular basis of vectorial transport in the kidney Seminars in Nephrology 18(2): 152-166
Arao, T.; Kudo, M.; Nishio, K. 2010: Searching for biological markers of molecular targeting treatment of liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1879-1882
Kuzuya, T.; Tsuchiya, K.; Izumi, N. 2010: Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1883-1886
Setterquist, R.A.; Smith, G.K.; Jones, R.; Fox, G.E. 1996: Diagnostic probes targeting the major sperm protein gene that may be useful in the molecular identification of nematodes Journal of Nematology 28(4 Suppl): 414-421
Ames, J.B.; Ikura, M.; Stryer, L. 2000: Molecular structure of membrane-targeting calcium sensors in vision: recoverin and guanylate cyclase-activating protein 2 Methods in Enzymology 316: 121-132
Postow, M.A. 2018: Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? Clinical Advances in Hematology and Oncology: H&o 16(5): 353-355